These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 18346598)

  • 1. Prolactin awareness: an essential consideration for physical health in schizophrenia.
    Montejo AL
    Eur Neuropsychopharmacol; 2008 May; 18 Suppl 2():S108-14. PubMed ID: 18346598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual dysfunction in schizophrenia: focus on recent evidence.
    Baggaley M
    Hum Psychopharmacol; 2008 Apr; 23(3):201-9. PubMed ID: 18338766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
    Haddad PM; Wieck A
    Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
    Hummer M; Huber J
    Curr Med Res Opin; 2004; 20(2):189-97. PubMed ID: 15006013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
    Compton MT; Miller AH
    Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density.
    Stubbs B
    J Psychiatr Ment Health Nurs; 2009 Nov; 16(9):838-42. PubMed ID: 19824978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
    Nakajima M; Terao T; Iwata N; Nakamura J
    Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
    O'Keane V
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin?
    Knegtering H; van den Bosch R; Castelein S; Bruggeman R; Sytema S; van Os J
    Psychoneuroendocrinology; 2008 Jul; 33(6):711-7. PubMed ID: 18395353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
    Byerly M; Suppes T; Tran QV; Baker RA
    J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol Use Disorders Identification Test (AUDIT) scores are elevated in antipsychotic-induced hyperprolactinaemia.
    Lawford BR; Barnes M; Connor JP; Heslop K; Nyst P; Young RM
    J Psychopharmacol; 2012 Feb; 26(2):324-9. PubMed ID: 21262859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
    Haefliger T; Bonsack C
    Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].
    Riecher-Rössler A; Schmid C; Bleuer S; Birkhäuser M
    Neuropsychiatr; 2009; 23(2):71-83. PubMed ID: 19573500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the treatment of antipsychotic-induced sexual dysfunction and/or hyperprolactinemia among patients of the schizophrenia spectrum: a review.
    Nunes LV; Moreira HC; Razzouk D; Nunes SO; Mari Jde J
    J Sex Marital Ther; 2012; 38(3):281-301. PubMed ID: 22533871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication.
    Westheide J; Cohen S; Bender S; Cooper-Mahkorn D; Erfurth A; Gastpar M; Huber TJ; Maier W; Murafi A; Rothermund M; Signerski J; Sträter B; Teusch L; Weig W; Welling A; Kühn KU
    Pharmacopsychiatry; 2007 Jul; 40(4):140-5. PubMed ID: 17694475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.
    Bushe C; Shaw M
    J Psychopharmacol; 2007 Sep; 21(7):768-73. PubMed ID: 17606473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].
    Konarzewska B; Szulc A; Popławska R; Galińska B; Juchnowicz D
    Psychiatr Pol; 2008; 42(1):87-95. PubMed ID: 18567406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic-induced hyperprolactinaemia.
    Inder WJ; Castle D
    Aust N Z J Psychiatry; 2011 Oct; 45(10):830-7. PubMed ID: 21714721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual side effects associated with conventional and atypical antipsychotics.
    Compton MT; Miller AH
    Psychopharmacol Bull; 2001; 35(3):89-108. PubMed ID: 12397881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.